(UroToday.com) The 2021 American Society for Radiation Oncology (ASTRO) Hybrid Annual Meeting included a presentation by Dr. Patrick Cheung discussing long-term results from a prospective clinical trial assessing elective nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized-high-risk prostate cancer.